London, UK – 25 January 2018 – The life sciences team of international business communications consultancy Instinctif Partners welcomes the launch of the UK BioIndustry Association’s (BIA) report on the progression of the UK’s bioscience industry during 2017.
This report also contains members’ views on likely trends and topics likely to effect the industry in 2018. As part of this, Instinctif Partners was commissioned to provide an insight into how MiFID II (Markets in Financial Instruments Directive) - a major new piece of financial regulation which came into effect on 3 January 2018 – could impact the sector.
Key to Instinctif Partners’ findings were the likely fall in trading commissions and how, for small companies, this may spell the end of independent research which to date has been a core investor relations tool for them.
Melanie Toyne-Sewell, Partner, Life Sciences said: “MiFID II brings challenges but also presents a great opportunity to the life sciences industry.
“For some time now, Company executives have had to become expert communicators, explaining their business proposition to a broadly generalist investor base. As the BIA’s findings showed earlier in the year, the speed at which they are required to do so is greater than ever before.
“With reduced access to independent research, companies are going to have to decide how earlier and work harder to articulate their business models in an investor-friendly way.”
“For those willing to embrace the change, MiFID II is a real opportunity to stamp your authority on how you want to be perceived by current and new potential investors.”
About Instinctif Partners Life Sciences
Instinctif Partners is a leading international business communications consultancy and has recently been awarded International Agency of the Year at the PR Week Global Awards 2017. The firm has an exceptionally strong dedicated team focused in the Life Sciences sector. This Life Sciences practice has expertise across financial, corporate, healthcare and marketing communications, and integrates design and digital into its communications mix. Offering global outreach, its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.